Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00843414 · ClinicalTrials.gov registry record
Immunological Characterization of Bronchoalveolar Cells in Normals
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 1,232
- Enrollment target
NCT00843414 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 1,232 participants.
The verdict
NCT00843414 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 1,232 participants
- Enrollment target
Study Summary
To obtain the monocytes (white blood cells) from normal volunteers for the purpose of studying how proteins, fats, carbohydrates, as well as RNA and DNA for gene expression, relate to immunity. This information will be compared to other studies in patients with lung diseases such as Emphysema, Sarcoidosis, and Interstitial Pulmonary Fibrosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,232 participants |
| Start Date | 1978-03 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00843414
The ClinicalTrials.gov registry entry for NCT00843414 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00843414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00843414 about?
NCT00843414 is a clinical study titled "Immunological Characterization of Bronchoalveolar Cells in Normals". To obtain the monocytes (white blood cells) from normal volunteers for the purpose of studying how proteins, fats, carbohydrates, as well as RNA and DNA for gene expression, relate to immunity. This information will be compared to other studies in patients with lung diseases such as Emphysema, Sarco...
What is the current status of trial NCT00843414?
This trial is currently completed. The enrollment target is 1,232 participants. The study started on 1978-03. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT00843414?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.